ALFACELL CORP
10-Q, EX-27, 2000-12-15
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ALFACELL CORP, 10-Q, EX-10.24, 2000-12-15
Next: AMERICAN SOFTWARE INC, 10-Q, 2000-12-15



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     This schedule  contains summary  financial  information  extracted from the
Alfacell  Corporation Balance Sheet as of October 31, 2000 and the Statements of
Operations  for the three months ended  October 31, 2000 and is qualified in its
entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                            JUL-31-2001
<PERIOD-END>                                 OCT-31-2000
<CASH>                                           146,716
<SECURITIES>                                           0
<RECEIVABLES>                                          0
<ALLOWANCES>                                           0
<INVENTORY>                                            0
<CURRENT-ASSETS>                                 736,439
<PP&E>                                         1,148,978
<DEPRECIATION>                                 1,025,838
<TOTAL-ASSETS>                                   919,446
<CURRENT-LIABILITIES>                            524,700
<BONDS>                                                0
                                  0
                                            0
<COMMON>                                          18,816
<OTHER-SE>                                       346,850
<TOTAL-LIABILITY-AND-EQUITY>                     919,446
<SALES>                                                0
<TOTAL-REVENUES>                                   3,754
<CGS>                                                  0
<TOTAL-COSTS>                                    513,746
<OTHER-EXPENSES>                                       0
<LOSS-PROVISION>                                       0
<INTEREST-EXPENSE>                                 1,901
<INCOME-PRETAX>                                 (511,893)
<INCOME-TAX>                                     451,395
<INCOME-CONTINUING>                              (60,498)
<DISCONTINUED>                                         0
<EXTRAORDINARY>                                        0
<CHANGES>                                              0
<NET-INCOME>                                     (60,498)
<EPS-BASIC>                                         0.00
<EPS-DILUTED>                                       0.00



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission